Shares of Teladoc Health Inc. (NYSE:TDOC) are trading lower today following an analyst downgrade.
Why Is It Moving?
Shares are down after Guggenheim downgraded the stock from Neutral to Sell and lowered its price target to $25. The firm reportedly cited slowing growth following the company's pandemic-driven boom.
This reportedly marks Teladoc’s first sell rating from a Wall Street analyst and it seems to be worrying investors.
TDOC Price Action: Shares are down 6.55% at $36.87 during Wednesday's premarket trading session, according to Benzinga Pro.
Photo: Courtesy of the National Cancer Institute on Unsplash
